Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments
- 1st Edition - April 1, 2026
- Latest edition
- Editors: Tuan Anh Nguyen, Bhupendra G. Prajapati, Devesh U. Kapoor
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 4 5 7 9 - 8
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 4 5 8 0 - 4
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the bo… Read more
Purchase options
Two Sides of Nanovaccines and Nanomedicines in Cancer Treatments provides a balanced exploration of the dual roles of nanotechnologies in oncology. Structured in four parts, the book begins with foundational knowledge of nanovaccines and nanomedicines, detailing their applications in cancer care and highlighting their precision in targeting cancer cells while reducing systemic toxicity. Importantly, the book addresses potential drawbacks, discussing side effects and safety concerns associated with these innovations. The final section emphasizes ethical, regulatory, and safety challenges, underscoring the need for careful oversight as nanotechnologies advance. For the academic audience, this book serves as a vital resource, offering insights that equip researchers and healthcare professionals to make informed decisions regarding clinical applications. Its focus on both the benefits and risks, alongside forward-looking perspectives, ensures that readers are well-prepared for future developments in the field of nanomedicine and cancer therapy.
• Provides an in-depth foundation on nanovaccines and nanomedicines, detailing their mechanisms, roles, and applications in cancer treatment
• Addresses both the advantages and potential side effects of nanovaccines and nanomedicines
• Emphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings
• Addresses both the advantages and potential side effects of nanovaccines and nanomedicines
• Emphasizes the ethical, safety, and regulatory aspects of nanotechnology in cancer therapy, offering valuable guidance for responsible usage and oversight in clinical settings
Researchers, academics and post graduate students in the fields of oncology, pharmacology, nanotechnology, and biomedical engineering
Part 1: Fundamentals
1. Introduction to nanovaccine in cancer treatments
2. Introduction to nanomedicine in cancer treatments
3. Sensors for Cancer Detection
4. Current Perspectives of Nanomedicines (in Cancer Treatment)
5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)
Part 2: Advantage and Application of Nanovaccine and Nanomedicine
6. Advantage of cancer Nanomedicine
7. Advantage of Targeted Nanomedicine (in Cancer Treatment)
8. Advantage of nanovaccine (in cancer treatment)
9. Nanovaccines and Nanomedicines in cancer treatment: Current Landscape
Part 3: The Other Side of Nanovaccine and Nanomedicine
10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)
11. Side effect and toxicity of nanomedicine (in cancer treatment)
12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy
13. Side effects and toxicity of nanoparticles in cancer treatment
14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications
15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine
16. Nanotoxicity/nano-genotoxicity in cancer care
17. Toxicity evaluation and management for nanoparticles used in the cancer therapy
18. Nanoparticle Toxicity in Cancer Nanomedicine
Part 4: Challenge and Perspectives
19. Nano-medicines and Nano-vaccines Manufacturing
20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment
21. Ethics in Cancer Nanomedicine
22. Ethics and regulations in nanomedicine/nanovaccines
23. Regulating nanomedicine: challenges and opportunities
24. Safety Assessment for Nanomedicines and Nanovaccines
25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues
26. Future perspectives of nanovaccines and nanomedicines
1. Introduction to nanovaccine in cancer treatments
2. Introduction to nanomedicine in cancer treatments
3. Sensors for Cancer Detection
4. Current Perspectives of Nanomedicines (in Cancer Treatment)
5. Current Perspectives of Nanovaccines and Nanomedicines (in Cancer Treatment)
Part 2: Advantage and Application of Nanovaccine and Nanomedicine
6. Advantage of cancer Nanomedicine
7. Advantage of Targeted Nanomedicine (in Cancer Treatment)
8. Advantage of nanovaccine (in cancer treatment)
9. Nanovaccines and Nanomedicines in cancer treatment: Current Landscape
Part 3: The Other Side of Nanovaccine and Nanomedicine
10. Side Effect and Toxicity of Nanovaccine (in Cancer Treatment)
11. Side effect and toxicity of nanomedicine (in cancer treatment)
12. Crossing the Barrier, Crossing the Line: Neurotoxicity of Nanomedicines in Brain Cancer Therapy
13. Side effects and toxicity of nanoparticles in cancer treatment
14. Toxicity of Metal Oxide Nanoparticles in Nanomedicine. Mechanisms and Implications
15. Nanotoxicity, safety assessment, regulatory aspect and clinical trial of nanovaccines/nanomedicine
16. Nanotoxicity/nano-genotoxicity in cancer care
17. Toxicity evaluation and management for nanoparticles used in the cancer therapy
18. Nanoparticle Toxicity in Cancer Nanomedicine
Part 4: Challenge and Perspectives
19. Nano-medicines and Nano-vaccines Manufacturing
20. Ethics in Nanomedicine and Nanovaccine in Cancer Treatment
21. Ethics in Cancer Nanomedicine
22. Ethics and regulations in nanomedicine/nanovaccines
23. Regulating nanomedicine: challenges and opportunities
24. Safety Assessment for Nanomedicines and Nanovaccines
25. Manufacturing of nanomedicine/nanovaccine on Large Scale: Challenges and Issues
26. Future perspectives of nanovaccines and nanomedicines
- Edition: 1
- Latest edition
- Published: April 1, 2026
- Language: English
TN
Tuan Anh Nguyen
Tuan Anh Nguyen is a Senior Principal Research Scientist at the Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, Vietnam. He received a BS in physics from Hanoi University in 1992, a BS in economics from Hanoi National Economics University in 1997, and a PhD in chemistry from the Paris Diderot University, France, in 2003. He was a Visiting Scientist at Seoul National University, South Korea, in 2004, and the University of Wollongong, Australia, in 2005. He then worked as a Postdoctoral Research Associate and Research Scientist at Montana State University, United States in 2006-09. In 2012 he was appointed as the Head of the Microanalysis Department at the Institute for Tropical Technology. His research areas of interest include smart sensors, smart networks, smart hospitals, smart cities, complexiverse, and digital twins. He has edited more than 74 books for Elsevier, 12 books for CRC Press, 1 book for Springer, 1 book for RSC, and 2 books for IGI Global. He is the Editor-in-Chief of Kenkyu Journal of Nanotechnology & Nanoscience.
Affiliations and expertise
Senior Principal Research Scientist, Institute for Tropical Technology, Vietnam Academy of Science and Technology, Hanoi, VietnamBP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaDK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, where he has served since September 2010. He holds a B.Pharm from the University of Rajasthan and an M.Pharm in Pharmaceutics from Rajasthan University of Health Sciences, along with a PhD in pharmaceutical sciences. With 14 years of teaching and administrative experience, Dr. Kapoor has authored over 35 research and review articles in esteemed national and international journals and contributed to several books published by Elsevier, Bentham Science, MDPI, Springer, and Wiley. His research focuses on osmotic drug delivery systems, solid lipid nanoparticles, and microspheres. He has received significant grants for organizing national seminars and faculty development programs. Dr. Kapoor holds three design patents and has delivered over 10 expert talks at various national conferences. He is currently the editor of three international books with prominent publishers.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, India